TOB2 and atrial fibrillation: hsa-miR-146b-5p, targeting anti-proliferative protein TOB2, has been shown to positively regulate the cell cycle and the following angiogenic process, thereby inducing or enhancing the development of AF by inflammation or fibrosis [72–74].